Cephalexin NDC 62135-480

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-480Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0480Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-480-42	62135048042	100 mL in 1 BOTTLE (62135-480-42)Marketed from Feb 1, 2022
62135-480-49	62135048049	200 mL in 1 BOTTLE (62135-480-49)Marketed from Feb 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cephalexin
Generic name (nonproprietary): cephalexin
Active ingredients: Cephalexin — 125 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065336
Marketing start: Feb 28, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 62135-480_459b5240-6bbf-1d2d-e063-6294a90aac45SPL ID 459b5240-6bbf-1d2d-e063-6294a90aac45SPL set ID 8a09bccd-1864-4dc3-9c31-6187d8e0fc99RxCUI 309110, 309113UNII OBN7UDS42YUPC 0362135480493, 0362135481421, 0362135481490, 0362135480424
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135048042 followed by a unit qualifier and the quantity

Package 62135-0480-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2025.

Indications (excerpt from the label)

Cephalexin for oral suspension, USP is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media ( 1.2 ) Skin and skin structure infections ( 1.3 ) Bone infections ( 1.4 ) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cephalexin for oral suspension, USP and other antibacterial drugs, Cephalexin for oral suspension, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. ( 1.6 ) 1.1 Respiratory Tract Infections Cephalexin is ind…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065336

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065336
Product	Strength	Form · route	Labeler	Product NDC
Cephalexin	Cephalexin 250 mg/5mL	Powder, For suspensionOral	Chartwell RX, LLC	62135-481